MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Cambridge Nutritional shares rise as health and safety case concludes

ALN

Cambridge Nutritional Sciences PLC on Friday said it has been fined £35,000 for safety breaches at a former subsidiary, as sentencing found ‘no deliberate breach or flagrant disregard for the law’.

Shares in Cambridge Nutritional Sciences were up 17% to 2.99 pence in London on Friday morning.

The London-based medical diagnostics firm said Thursday’s sentencing related to legal proceedings against wholly-owned subsidiary Omega Diagnostics Ltd, brought by the Health & Safety Executive, related to four breaches of health and safety regulations in 2018.

The company noted that the breaches relate to Omega South West, which was previously owned by Omega Diagnostics but was sold in 2018. Omega Diagnostics entered guilty pleas in March.

The court found that there was no deliberate breach or flagrant disregard for the law, no aggravating factors and ‘substantial mitigating factors’.

The mitigating factors included no previous convictions, a good health and safety record, full cooperation, sincere regret expressed and that the breaches occurred over a narrow window of time, Cambridge Nutritional Sciences noted.

The court imposed a total fine of £35,000.

The company said the matter has formally concluded, and there is no further liability or legal action expected.

It said the financial impact of the fine has been fully provided for within its existing provisions. There will be no material effect on its financial performance, Cambridge Nutritional Sciences added.

‘The board reaffirms its commitment to upholding the highest standards of compliance and corporate responsibility across all of its operations,’ it said.

Copyright 2025 Alliance News Ltd. All Rights Reserved.